Medidata to Present at Upcoming Investor Conferences

NEW YORK–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/MDSO?src=hash” target=”_blank”gt;#MDSOlt;/agt;–Medidata
(NASDAQ: MDSO) today announced its participation in two upcoming
investor conferences.

  • Rouven Bergmann, chief financial officer, will present at the Morgan
    Stanley Technology, Media & Telecom Conference on Wednesday, Feb. 27,
    2019, in San Francisco at 2:05 p.m. PT (5:05 p.m. ET).
  • Dr. Bergmann will also present at the 8th Annual SVB Leerink Global
    Healthcare Conference on Friday, March 1, 2019, in New York at 11:00
    a.m. ET.

A live audio webcast and replay of each presentation will be available
at http://investor.mdsol.com.

About Medidata

Medidata is leading the digital transformation of life sciences, with
the world’s most used platform for clinical development, commercial, and
real-world data. Powered by artificial intelligence and delivered by the
#1 ranked industry experts, the Intelligent Platform for Life Sciences
helps pharmaceutical, biotech, medical device companies, and academic
researchers accelerate value, minimize risk and optimize outcomes.
Medidata serves more than 1,000 customers and partners worldwide and
empowers more than 100,000 certified users every day to create hope for
millions of patients. Discover the future of life sciences: www.medidata.com

Contacts

Medidata Solutions Contacts:
Investors:
Betsy
Frank, 917-522-4620
bfrank@medidata.com
or
Media:
Erik
Snider, 646-362-2997
esnider@medidata.com

error: Content is protected !!